Julie Massayo Maeda Oda

CXCL12 rs1801157 polymorphism in patients with breast cancer, hodgkin's lymphoma, and non‐hodgkin's lymphoma

Karen Brajão de Oliveira, Julie Massayo Maeda Oda, Júlio César Voltarelli et al. · Journal of Clinical Laboratory Analysis · 2009 · 42 citations

Breast Oncology, Chemokine Biology, Immunology +19

CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients

Karen Brajão de Oliveira, Roberta Losi Guembarovski, Julie Massayo Maeda Oda et al. · Cytokine · 2011 · 32 citations · Full text

Cxcl12 Rs1801157 Polymorphism, Breast Oncology, Oncology +12

<i>FOXP3 Transcription Factor</i>: A Candidate Marker for Susceptibility and Prognosis in Triple Negative Breast Cancer

Leandra Fiori Lopes, Roberta Losi Guembarovski, Alda Losi Guembarovski et al. · BioMed Research International · 2014 · 26 citations · Full text

Breast Oncology, Immunology, Pathology +19

The effect of propolis on CCL5 and IFN-<i>γ</i> expression by peripheral blood mononuclear cells from leishmaniasis patients

Marla Karine Amarante, Maria Angélica Ehara Watanabe, Ivete Conchon‐Costa et al. · Journal of Pharmacy and Pharmacology · 2011 · 22 citations · Full text

CXCL12 and TP53 genetic polymorphisms as markers of susceptibility in a Brazilian children population with acute lymphoblastic leukemia (ALL)

Aparecida de Lourdes Perim, Roberta Losi Guembarovski, Julie Massayo Maeda Oda et al. · Molecular Biology Reports · 2013 · 22 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +12